Cancer Vaccine Co. Files For Chapter 7

Law360, New York (November 22, 2006, 12:00 AM EST) -- Therion Biologics Corp., a company that develops vaccines that train the body’s immune system to fend off cancer without the side effects associated with chemotherapy, filed for Chapter 7 on Tuesday.

The Cambridge, Mass.-based company’s bankruptcy petition listed both its assets and debts as between $1 million and $100 million.

In June, one of Therion’s two candidates for lead product used to treat pancreatic cancer fell short in clinical tests, prompting the company to not pursue licensing of the drug with the U.S. Food and Drug...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.